T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rivian
RIVN
|
+$18.7B |
| 2 |
Apple
AAPL
|
+$5.48B |
| 3 |
NVIDIA
NVDA
|
+$5.33B |
| 4 |
Tesla
TSLA
|
+$4.47B |
| 5 |
Microsoft
MSFT
|
+$2.15B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$4.26B |
| 2 |
Meta Platforms (Facebook)
META
|
+$3.3B |
| 3 |
Morgan Stanley
MS
|
+$2.82B |
| 4 |
Global Payments
GPN
|
+$2.43B |
| 5 |
PayPal
PYPL
|
+$2B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.36% |
| 2 | Healthcare | 16.09% |
| 3 | Consumer Discretionary | 15.79% |
| 4 | Communication Services | 12.38% |
| 5 | Financials | 10.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
701
Towne Bank
TOWN
$3.49B
| $124M | 0.01% |
3,938,907
-91,557
| -2% | -$2.92M |
|
702
National Bank Holdings
NBHC
$1.94B
| $124M | 0.01% |
2,826,056
-35,870
| -1% | -$1.56M |
|
703
Ford
F
$55.3B
| $123M | 0.01% |
5,919,332
-161,087
| -3% | -$2.96M |
|
704
Floor & Decor
FND
$6.27B
| $122M | 0.01% |
941,720
+44,097
| +5% | +$5.68M |
|
705
Edwards Lifesciences
EW
$53.3B
| $122M | 0.01% |
944,703
-30,418
| -3% | -$3.55M |
|
706
Tetra Tech
TTEK
$9.33B
| $122M | 0.01% |
3,603,555
-184,720
| -5% | -$6.36M |
|
|
HTO
707
H2O America
HTO
$2.65B
| $121M | 0.01% |
1,650,807
-151,454
| -8% | -$10.5M |
|
708
Mueller Water Products
MWA
$4B
| $121M | 0.01% |
8,369,160
+388,545
| +5% | +$5.84M |
|
709
Westlake Corp
WLK
$10.2B
| $120M | 0.01% |
1,237,040
-1,341
| -0.1% | -$131K |
|
710
Radian Group
RDN
$4.92B
| $120M | 0.01% |
5,660,184
-115,923
| -2% | -$2.57M |
|
|
MODV
711
DELISTED
ModivCare
MODV
| $119M | 0.01% |
804,504
-19,486
| -2% | -$3.01M |
|
712
US Physical Therapy
USPH
$1.23B
| $118M | 0.01% |
1,239,032
-47,541
| -4% | -$4.77M |
|
713
Pacific Biosciences
PACB
$364M
| $118M | 0.01% |
5,833,804
+84,468
| +1% | +$2.04M |
|
714
Utz Brands
UTZ
$1.25B
| $118M | 0.01% |
7,390,339
-234,465
| -3% | -$3.73M |
|
715
Kimco Realty
KIM
$16.3B
| $118M | 0.01% |
4,777,168
+1,351,694
| +39% | +$31.3M |
|
|
PCH
716
DELISTED
PotlatchDeltic
PCH
| $117M | 0.01% |
1,942,980
-18,035
| -0.9% | -$1.01M |
|
717
Arthur J. Gallagher & Co
AJG
$65.2B
| $117M | 0.01% |
688,464
+96,252
| +16% | +$15.7M |
|
718
Gartner
IT
$11.6B
| $116M | 0.01% |
347,887
-3,494
| -1% | -$1.12M |
|
719
Liberty Energy
LBRT
$3.45B
| $115M | 0.01% |
11,850,048
-778,492
| -6% | -$9.04M |
|
720
Moody's
MCO
$84.7B
| $114M | 0.01% |
292,637
-7,681
| -3% | -$2.96M |
|
721
Exponent
EXPO
$3.25B
| $113M | 0.01% |
970,181
-18,752
| -2% | -$2.2M |
|
722
CTS Corp
CTS
$1.77B
| $113M | 0.01% |
3,071,053
-389,391
| -11% | -$13.6M |
|
723
TransDigm Group
TDG
$68.6B
| $113M | 0.01% |
177,144
-2,243
| -1% | -$1.4M |
|
724
Alamo Group
ALG
$2B
| $112M | 0.01% |
764,041
-2,909
| -0.4% | -$431K |
|
|
ELME
725
Elme Communities
ELME
$144M
| $112M | 0.01% |
4,344,761
-49,357
| -1% | -$1.26M |
|
Similar funds
T. Rowe Price Associates's Q4 2021 Portfolio in Review
As of Q4 2021, T. Rowe Price Associates held 3,121 positions worth $1.11T, up 4.6% from $1.06T the previous quarter. Its ten largest holdings account for 28% of the portfolio.
T. Rowe Price Associates's Q4 2021 filing shows 186 new, 817 increased, 1,825 reduced and 148 closed positions. Its largest new stake was Rivian: 162,080,423 shares worth $16.1B. The largest sale was Visa, an estimated $4.26B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q4 2021 buy was Rivian: 162,080,423 shares worth $16.1B.
- T. Rowe Price Associates added most to Apple in Q4 2021, an estimated $5.48B increase.
- T. Rowe Price Associates's biggest Q4 2021 reduction was Visa, cutting an estimated $4.26B.
- T. Rowe Price Associates fully exited Acceleron Pharma in Q4 2021, selling an estimated $923M.
- T. Rowe Price Associates's ten largest holdings make up 28% of its $1.11T portfolio in Q4 2021.
- T. Rowe Price Associates opened 186 new positions and closed 148 in Q4 2021.
- T. Rowe Price Associates's portfolio value rose 4.6% quarter-over-quarter to $1.11T.
Based on T. Rowe Price Associates's 13F filing for Q4 2021, filed 14 Feb 2022.